NCT03746457 (RISHTA) is a NA clinical trial of Behavioral intervention in Alcohol Consumption, sponsored by UConn Health.

Who is sponsoring NCT03746457?

NCT03746457 is sponsored by UConn Health.

What drugs are being tested in NCT03746457?

Interventions in NCT03746457: Behavioral intervention.

What condition does NCT03746457 study?

NCT03746457 studies Alcohol Consumption, HIV Infection Primary.

Is NCT03746457 still recruiting?

NCT03746457 is currently completed. Last updated 11 December 2018.

Last reviewed 2018-12-11 · How we verify

NCT03746457: RISHTA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alcohol and ART Adherence in India

Completed NA Last updated 11 December 2018

What this trial tests

NA trial testing Behavioral intervention in Alcohol Consumption in 940 participants. Completed in 15 October 2018.

Timeline

10 May 2015

Primary endpoint
15 October 2018

15 October 2018

Quick facts

Lead sponsor	UConn Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	940
Start date	10 May 2015
Primary completion	15 October 2018
Estimated completion	15 October 2018
Sites	1 location across United States

Drugs / interventions tested

Behavioral intervention

Conditions studied

Alcohol Consumption — all drugs for Alcohol Consumption →
HIV Infection Primary — all drugs for HIV Infection Primary →

Sponsor

UConn Health — full company profile →

Who can join

Adults 18 to 60, male only, with Alcohol Consumption or HIV Infection Primary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The focus of this project was to reduce alcohol consumption among male "persons living with HIV" (PLHIV) on antiretroviral treatment (ART) at government hospitals in urban Maharashtra, India and factors associated with both these outcomes including depression, stigma, social support networks, quality of life and health status. The project consisted of three phases; formative research, implementation of multilevel interventions and analysis of process and outcome data. The project utilized a crossover design to compare outcomes of individual interventions and the sequences of intervention.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Multilevel and Multifactorial Interventions to Reduce Alcohol Consumption and Improve ART Adherence and Related Factors Among HIV Positive Men in Mumbai, India.
Schensul SL, Ha T, Schensul JJ, Grady J, et al · · 2021 · cited 11× · PMID 34014429 · DOI 10.1007/s10461-021-03303-y
Assessing the Effectiveness of Multilevel Intervention Sequences on "Tension" Among Men Living with HIV: A Randomized-Control Trial.
Ha T, Shi H, Pham BN, Dsouza A, et al · · 2025 · cited 2× · PMID 39073518 · DOI 10.1007/s12529-024-10310-5
The Mediating Effect of Changes in Depression Symptoms on the Relationship between Health-Related Quality of Life and Alcohol Consumption: Findings from a Longitudinal Study among Men Living with HIV in India.
Ha T, Shi H, Shrestha R, Gaikwad SS, et al · · 2023 · cited 1× · PMID 37107849 · DOI 10.3390/ijerph20085567
Impact of multilevel interventions on reducing reasons for drinking among men living with HIV.
Ha T, Pham TQ, Misra S, Su TW, et al · · 2025 · PMID 40844326 · DOI 10.1080/09540121.2025.2547030
Modeling HIV Transmission from Sexually Active Alcohol-Consuming Men in ART Programs to Seronegative Wives.
Dieckhaus KD, Ha TH, Schensul SL, Sarna A. · · 2020 · PMID 32851898 · DOI 10.1177/2325958220952287

Verify or expand the search:

Other trials of Behavioral intervention

Trials testing the same drug.

NCT03705702 — Behavioral Intervention to Increase Physical Activity in Patients With Asthma · NA · completed
NCT03773250 — A FAMILY Program for Childhood Overweight and Obesity · NA · completed

Other recruiting trials for Alcohol Consumption

Currently open trials in the same condition.

NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT06962592 — Mentor Moms+ Study · NA · recruiting
NCT06617702 — Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial · NA · recruiting
NCT06856161 — A Novel Blood Test as a Biomarker in Mental Health · recruiting
NCT06770556 — Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study · NA · recruiting

Other UConn Health trials

Trials by the same sponsor.

NCT06115252 — Partnering to Enhance Emerging Adults' Response to Programs · NA · recruiting
NCT04598074 — Opioid Package Prototype (OPP) · NA · not yet recruiting
NCT06846853 — Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging) · Phase 4 · recruiting
NCT06731764 — Novel Approaches to the Treatment of Hypothyroidism · Phase 2, PHASE3 · recruiting
NCT06668194 — Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03746457 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UConn Health
Last refreshed: 11 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03746457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing